title: [Clinical study of advanced nasopharyngeal carcinoma treated with radiotherapy combined with DDP and vindesine].
abstract: OBJECTIVE
  To evaluate the result of radiotherapy combined with chemotherapy for advanced nasopharyngeal carcinoma (NPC).
  
  
  METHODS
  From August 1996 to October 1997, 64 cases of advanced NPC (stage N2-N3) patients were randomized to receive radiotherapy (RT) alone or RT combined with 2 cycles of chemeotherapy (CT) (cisplatin, vindesine). Thirty two patients were assigned to CT + RT, and 32 to RT alone.
  
  
  RESULTS
  At 40 Gy of RT the response rate was 28.1% in RT group and 43.8% in CT + RT group. The response rate at 3 months after RT was 75.0% in RT group and 84.4% in CT + RT group (P < 0.05). The major toxic effects were gastrointestinal reaction, myelosuppession and alopecia.
  
  
  CONCLUSIONS
  Chemotherapy with cisplatin and vindesine before and after radiotherapy increases the response rate of advanced NPC with lymph node metastases.
authors.affiliation: Cancer Center of Sun Yatsen, Universiey of Medical Sciences, Guangzhou 510060.
authors.forename: M
authors.initials: M
authors.lastname: Liu
authors.forename: H
authors.initials: H
authors.lastname: Liu
authors.forename: Z
authors.initials: Z
authors.lastname: Mao
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D014751:Vindesine / Q000008:administration & dosage
chemical_list: D002945:Cisplatin; D014751:Vindesine